Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 25, 2023

Efficacy of Single-Agent Chemotherapy in Patients With Endocrine Therapy–Refractory Metastatic Invasive Lobular Carcinoma

The Oncologist


Additional Info

The Oncologist
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma
Oncologist 2023 Dec 09;[EPub Ahead of Print], JA Mouabbi, W Qaio, Y Shen, AS Raghavendra, D Tripathy, RM Layman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading